A new treatment that uses the body’s own immune system (immunotherapy), could revolutionise medication for very young children with a moderate to severe form of a common skin condition.
Read more
A COVID-19 vaccine study, analysing third dose booster options for 12 to 15-year-olds, is open at Royal Manchester Children’s Hospital.
Read more
The outstanding commitment to critical care research by a children’s intensive care research team at Manchester University NHS Foundation Trust (MFT) has received national recognition.
Read more
Seven Manchester University NHS Foundation Trust (MFT) Consultants, are among 16 outstanding individuals announced by Manchester Academic Health Science Centre (MAHSC).
Read more
In her blog Gabby Addison shares her student nurse experiences at the NIHR Manchester Clinical Research Facility, and how she is proud to be back as a Clinical Research Nurse.
Read more
Children in the UK will be able to receive Palforzia – a life-changing oral treatment for peanut allergies – as NHS standard of care following approval for use by NICE.
Read more
The NHS has struck a deal for a life-saving treatment that will offer babies and young children with a rare and life-limiting genetic disease the prospect of a normal life.
Read more
A Royal Manchester Children’s Hospital patient is the first young person in the world to participate in a study researching a new drug to treat itching caused by kidney failure.
Read more
